HIGHLIGHTS
- who: P. H. A. Wisse from the Department of Pathology, Netherlands Cancer Institute, Plesmanlaan, Amsterdam, CX, the Netherlands have published the research: The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design, in the Journal: (JOURNAL)
- what: The authors aim to determine relative sensitivity for AN comprising of CRC adenomas and serrated polyps of mtFIT compared to FIT at an equal positivity rate. The authors aim to assess the long-term cost-effectiveness of mtFIT- versus FIT-based programmatic CRC screening. under . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.